Operational procedure sharing pathway in veno-occlusive disease: a Delphi consensus-based recommendations

被引:0
|
作者
Bonifazi, Francesca [1 ]
Ravaioli, Federico [1 ]
Iori, Anna Paola [2 ]
Milone, Giuseppe [3 ]
Olivieri, Attilio [4 ]
Prete, Arcangelo [1 ]
Russo, Domenico [5 ]
Santarone, Stella [6 ]
Sica, Simona [7 ,8 ]
Zecca, Marco [9 ]
Colecchia, Antonio [10 ]
DELPHI VODExpert Panel
机构
[1] Azienda Osped Univ Bologna, Dept Translat & Precis Med, Ist Ricovero & Cura Carattere Sci IRCCS, Bologna, Italy
[2] Sapienza Univ Rome, Dept Translat & Precis Med, Div Allogene Transplantat, Rome, Italy
[3] Azienda Osped Univ Policlin G Rodol San Marco, Hematol & Bone Marrow BMT Unit, Catania, Italy
[4] Univ Politecn Marche, Clin Ematol, Ancona, Italy
[5] Univ Brescia, Dept Clin & Expt Sci, Cell Therapies & Hematol Res Program, Unit Blood Dis & Bone Marrow Transplantat,Azienda, Brescia, Italy
[6] Osped Civile, Dept Hematol Transfus Med & Biotechnol, Pescara, Italy
[7] Fdn Policlin Univ Agostino Gemelli IRCCS, Dipartimento Sci Lab Ematol, Sez Ematol, Rome, Italy
[8] Univ Cattolica Sacro Cuore, Dipartimento Sci Radiol & Ematol, Rome, Italy
[9] Fdn IRCCS Policlin San Matteo, Roma Dept Pediat Hematol Oncol, Modena, Pavia, Italy
[10] Univ Modena & Reggio Emilia, Dipartimento Chirurg Med Odontoiatr & Sci Morfolog, Gastroenterol Unit, Modena, Italy
来源
FRONTIERS IN ONCOLOGY | 2025年 / 15卷
关键词
veno-occlusive disease (VOD); Delphi; ETE; methodology; SOS; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; SYNDROME/VENO-OCCLUSIVE DISEASE; SINUSOIDAL OBSTRUCTION SYNDROME; EUROPEAN-SOCIETY; SEVERITY CRITERIA; LIVER TOXICITY; DEFIBROTIDE; DIAGNOSIS; BLOOD;
D O I
10.3389/fonc.2025.1498782
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The hepatic Veno-Occlusive Disease (VOD), also known as Sinusoidal Obstruction Syndrome (SOS), is a serious complication that can occur after high-dose chemotherapy and hematopoietic stem cell transplantation (HSCT). In Italy, the approach to VOD varies due to differences in healthcare practices and diagnostic criteria among different regions.Aim and methods To address this issue, a structured, multi-step Delphi consensus project was undertaken with the aim of standardizing the diagnostic and therapeutic pathways for VOD in Italian clinical practice. The project involved a methodologist, a scientific board of 10 experts, and an expert panel of 45 specialists from Italian hospital centers. This 12-month process included independent contributions, harmonization by a methodologist, and discussions through web meetings.Results The survey identified 15 clinical topics divided into five key areas, including pre-HSCT patient evaluation, clinical-laboratory aspects for diagnosis and therapy, integration of clinical evaluations with EBMT criteria, monitoring with imaging techniques, and adherence to guidelines for managing defibrotide therapy. Key findings include the recommendation of weekly imaging even when VOD is not clinically suspected, the importance of early diagnosis and treatment with defibrotide, and the need for a standardized approach across different centers.Conclusion The Delphi consensus revealed significant variability in the management of VOD across Italian centers and emphasized the necessity of a multidisciplinary approach involving hematologists, hepatologists, and radiologists. Establishing a national network for sharing best practices and utilizing advanced imaging technologies is essential for improving VOD diagnosis and treatment. The findings indicate the importance of implementing standardized protocols and continuous education to enhance patient outcomes in HSCT settings.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Veno-occlusive Disease: Online, Interprofessional, Case-based Education Significantly Improves Knowledge and Skills of the Entire Care Team
    Willis, Lauren
    Tanzola, Mindy
    Abair, Tristin
    Chen, Pan
    Jennissen, Cathryn
    Bemis, Alison
    Smith, Angela R.
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 600 - 601
  • [32] CONSENSUS-BASED PRIORITIES FOR OUTCOMES IN CLINICAL TRIALS INVOLVING ADULTS WITH CHRONIC KIDNEY DISEASE: A MULTINATIONAL DELPHI SURVEY
    Matus, Andrea
    NEPHROLOGY, 2023, 28 : 46 - 46
  • [33] Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management
    Al Jefri, A. H.
    Abujazar, H.
    Al-Ahmari, A.
    Al Rawas, A.
    Al Zahrani, Z.
    Alhejazi, A.
    Bekadja, M. A.
    Ibrahim, A.
    Lahoucine, M.
    Ousia, S.
    Bazarbachi, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (04) : 588 - 591
  • [34] Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management
    A H Al Jefri
    H Abujazar
    A Al-Ahmari
    A Al Rawas
    Z Al Zahrani
    A Alhejazi
    M A Bekadja
    A Ibrahim
    M Lahoucine
    S Ousia
    A Bazarbachi
    Bone Marrow Transplantation, 2017, 52 : 588 - 591
  • [35] Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts
    Leavis, Helen L.
    van Daele, Paul L. A.
    Mulders-Manders, Catharina
    Michels, Renee
    Rutgers, Abraham
    Legger, Elizabeth
    Bijl, Marc
    Hak, Elisabeth A.
    Lam-Tse, Wai-Kwan
    Bonte-Mineur, Femke
    Fretter, Peter
    Simon, Anna
    van Paassen, Pieter
    van der Goes, Marlies C.
    Flendrie, Marcel
    Vercoutere, Ward
    van Lieshout, Antoine W. T.
    Leek, Arjen
    Vastert, Sebastiaan J.
    Tas, Sander W.
    RHEUMATOLOGY, 2024, 63 (06) : 1656 - 1663
  • [36] Sinusoidal obstruction syndrome/veno-occlusive disease complication in lymphoma patients treated with oxaliplatin-based regimen: A case series report
    Bernichon, E.
    Daguenet, E.
    Molla, C.
    Cornillon, J.
    Lejeune, C.
    Casteillo, F.
    Guyotat, D.
    Tavernier, E.
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2018, 66 (04) : 107 - 110
  • [37] VENO-OCCLUSIVE DISEASE AFTER BONE-MARROW TRANSPLANTATION, PREVALENCE, PROGNOSIS, AND PREDISPOSING FACTORS - AN EXPERIENCE BASED ON 127 TRANSPLANT PATIENTS
    GIRARDIN, MFS
    DOUVIN, C
    CORDONNIER, C
    AVONS, P
    ZAFRANI, ES
    VERNANT, JP
    DHUMEAUX, D
    HEPATOLOGY, 1985, 5 (05) : 993 - 993
  • [38] Analysis of Genetic Variants Related to the Hepatic Veno-Occlusive Disease in Pediatric Patients Receiving HSCT with Targeted Dose Busulfan Based Conditioning
    Choi, Jung Yoon
    Seo, Heewon
    Park, Yoomi
    Min, ByungJoo
    Kim, Hyery
    Hong, Kyung Taek
    Hong, Che Ry
    Song, Sang Hoon
    Yu, Kyung-Sang
    Jang, In-Jin
    Park, Kyung Duk
    Shin, Hee Young
    Kim, Ju Han
    Kang, Hyoung Jin
    BLOOD, 2017, 130
  • [39] Early-onset hepatic veno-occlusive disease after liver transplantation: an institutional experience and analysis of a literature-based cohort
    Endo, Yutaka
    Shinoda, Masahiro
    Maehara, Junki
    Hibi, Taizo
    Hasegawa, Yasushi
    Obara, Hideaki
    Kitago, Minoru
    Ojima, Hidenori
    Tanabe, Minoru
    Kitagawa, Yuko
    SURGERY TODAY, 2024, 54 (07) : 670 - 682
  • [40] Ursodiol-based prophylaxis for veno-occlusive disease (VOD): A retrospective risk-based review of outcomes following allogeneic stem cell transplantation
    Thompson, JM
    Akard, LP
    Dugan, MJ
    English, K
    Jansen, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 88 - 88